Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julie, Burdin de Saint Martin"'
Autor:
Julie Burdin de Saint Martin, Michel Ducher, Sylvain Goutelle, Laurent Bourguignon, Pascal Maire, Anne Guillermet, Cécile Gérard
Publikováno v:
Therapies. 64:47-53
Resume L’utilisation de l’amikacine est delicate en raison de sa toxicite et de sa variabilite pharmacocinetique. Cette variabilite est pratiquement ignoree chez l’adulte puisque seul le poids est utilise dans le calcul de la dose a administrer
Autor:
Laurent, Bourguignon, Sylvain, Goutelle, Cécile, Gérard, Anne, Guillermet, Julie, Burdin de Saint Martin, Pascal, Maire, Michel, Ducher
Publikováno v:
Therapie. 64(1)
The use of amikacin is difficult because of its toxicity and its pharmacokinetic variability. This variability is almost ignored in adult standard dosage regimens since only the weight is used in the dose calculation. Our objective is to test if the
Autor:
Laurent Bourguignon, Sylvain Goutelle, Michel Ducher, Julie Burdin De Saint-Martin, Pascal Maire
Publikováno v:
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2009,--, pp.1-5
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2009,--, pp.1-5
Fundamental and Clinical Pharmacology, Wiley, 2009,--, pp.1-5
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2009,--, pp.1-5
The aim of this simulation study was to evaluate the ability of three regimens proposed in official French recommendations for gentamicin to hit defined pharmacokinetic (PK) and pharmacodynamic targets in a population of elderly patients. The first d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e03e310651e11232414192f53b800d7b
https://hal.archives-ouvertes.fr/hal-00539383
https://hal.archives-ouvertes.fr/hal-00539383
Autor:
Laurent, Bourguignon, Sylvain, Goutelle, Cécile, Gérard, Anne, Guillermet, Julie Burdin, de Saint Martin, Pascal, Maire, Michel, Ducher
Publikováno v:
Therapie. 64(1)
The use of amikacin is difficult because of its toxicity and its pharmacokinetic variability. This variability is almost ignored in adult standard dosage regimens since only the weight is used in the dose calculation. Our objective is to test if the